03:30–03:45 pm | Enhancer RNAs as modulators of the post-stroke chromatin landscape and pathophysiology
Ashutosh Dharap (Tampa, USA)
03:45–04:00 pm | Developing and validating Serine Gamma Peptide Nucleic Acid (sγPNA)-based miR-141-3p Inhibitors for Treatment of Ischemic Stroke
Rajkumar Verma (Farmington, USA)
04:00–04:15 pm | Development of a brain-accessible peptide containing neurotrophin receptor TrkB-T1 sequences that reduces reactive astrogliosis and leads to stroke neuroprotection
Lola Ugalde-Triviño (Madrid, Spain)
04:15–04:30 pm | Micro-RNA Alterations in Post-Stroke Brain Following Physical Exercise in Mice
Marta Klimczak (Barcelona, Spain)
04:30–04:45 pm | The miRNAs miR-3609 and miR-941, associated with cryptogenic stroke functional outcome, regulate αβ-crystallin expression
Guillem Cañellas-Calafat (Palma, Spain)
04:45–05:00 pm | Circular RNA circKlhl2 modulates TBI response influencing the BDNF pathway
Marica Pagliarini (Ulm, Germany)